We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

156 hedge funds and large institutions have $560M invested in SANGAMO THERAPEUTICS INC in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 47 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,968% more call options, than puts

Call options by funds: $142M | Put options by funds: $4.63M

13% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 47

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less funds holding

Funds holding: 171156 (-15)

32% less capital invested

Capital invested by funds: $825M → $560M (-$265M)

42% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 36

Holders
156
Holders Change
-15
Holders Change %
-8.77%
% of All Funds
4.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
53
Reduced
47
Closed
36
Calls
$142M
Puts
$4.63M
Net Calls
+$137M
Net Calls Change
-$54.5M
Name Holding Trade Value Shares
Change
Change in
Stake
TAM
26
Tocqueville Asset Management
New York
$5.12M +$219K +17,020 +4%
AC
27
Apex Capital
California
$4.88M +$514K +39,900 +10%
JHIU
28
Janus Henderson Investors US
Colorado
$4.86M -$17M -1,317,954 -75%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$4.78M +$252K +19,549 +5%
CS
30
Credit Suisse
Switzerland
$4.58M +$1.11M +86,141 +26%
Wellington Management Group
31
Wellington Management Group
Massachusetts
$4.57M +$84.3K +6,540 +2%
TA
32
Teachers Advisors
New York
$4.53M +$59.9K +4,645 +1%
Morgan Stanley
33
Morgan Stanley
New York
$4.43M -$423K -32,780 -8%
CAM
34
Cormorant Asset Management
Massachusetts
$4M -$1.04M -81,000 -18%
AGA
35
Altrinsic Global Advisors
Connecticut
$3.77M
TCIM
36
TIAA CREF Investment Management
New York
$3.71M -$395K -30,672 -8%
SM
37
Sabby Management
Florida
$3.59M +$821K +63,649 +25%
Point72 Asset Management
38
Point72 Asset Management
Connecticut
$3.55M +$1.6M +124,200 +63%
NI
39
Numeric Investors
Massachusetts
$3.34M +$2.37M +183,650 +156%
BIM
40
BlackRock Investment Management
Delaware
$2.6M +$597K +46,299 +25%
CNB
41
City National Bank
California
$2.46M -$5.4M -419,107 -65%
Charles Schwab
42
Charles Schwab
California
$2.4M -$1.44M -111,560 -34%
Fidelity International
43
Fidelity International
Bermuda
$2.34M -$713K -55,297 -21%
SCM
44
Suffolk Capital Management
New York
$2.19M +$2.54M +197,000 New
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$2.08M -$2.75M -213,004 -53%
OAM
46
Oxford Asset Management
United Kingdom
$1.97M +$524K +40,616 +30%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$1.96M -$74.3K -5,763 -3%
BA
48
BlackRock Advisors
Delaware
$1.95M -$151K -11,743 -6%
AIC
49
AWM Investment Company
New York
$1.8M -$129K -10,000 -6%
Wells Fargo
50
Wells Fargo
California
$1.71M +$606K +46,975 +44%

SGMO Hedge Fund Activity: Q2 2015 in Review

156 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2015, worth a combined $560M — down 32% from $825M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of SGMO and 21 opened new positions — a net loss of 15 holders — while 47 trimmed existing stakes and 53 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $23.5M. The largest seller was Janus Henderson Investors US, cutting an estimated $17M.

  • 156 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2015, down from 171 in Q1 2015.
  • Funds reported $560M of SANGAMO THERAPEUTICS INC stock for Q2 2015, down 32% quarter-over-quarter.
  • 21 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2015 and 36 closed out, a net change of -15 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2015 was Baker Bros. Advisors, an estimated $23.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2015 was Janus Henderson Investors US, an estimated $17M sold.

Based on aggregated 13F filings for Q2 2015.